These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. Marill KA; deSouza IS; Nishijima DK; Senecal EL; Setnik GS; Stair TO; Ruskin JN; Ellinor PT Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763 [TBL] [Abstract][Full Text] [Related]
4. Procainamide: a perspective on its value and danger. Ellenbogen KA; Wood MA; Stambler BS Heart Dis Stroke; 1993; 2(6):473-6. PubMed ID: 8137053 [TBL] [Abstract][Full Text] [Related]
5. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. Buxton AE; Josephson ME; Marchlinski FE; Miller JM J Am Coll Cardiol; 1993 Jan; 21(1):90-8. PubMed ID: 8417082 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Gold MR; O'Gara PT; Buckley MJ; DeSanctis RW Am J Cardiol; 1996 Nov; 78(9):975-9. PubMed ID: 8916473 [TBL] [Abstract][Full Text] [Related]
7. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia. Rials SJ; Britchkow D; Marinchak RA; Kowey PR Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804 [TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia. Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498 [TBL] [Abstract][Full Text] [Related]
9. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Gorgels AP; van den Dool A; Hofs A; Mulleneers R; Smeets JL; Vos MA; Wellens HJ Am J Cardiol; 1996 Jul; 78(1):43-6. PubMed ID: 8712116 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764 [TBL] [Abstract][Full Text] [Related]
11. Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction. Josephson ME Am J Cardiol; 1996 Jul; 78(1):82-3. PubMed ID: 8712123 [No Abstract] [Full Text] [Related]
12. Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant. Hiremath G; Li W; Foltz R; Roy-Burman A; Cocalis M; Tanel RE Pediatr Emerg Care; 2015 Jan; 31(1):50-3. PubMed ID: 25526021 [TBL] [Abstract][Full Text] [Related]
13. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis. Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610 [TBL] [Abstract][Full Text] [Related]
14. Electrical proarrhythmia with procainamide: a new ICD-drug interaction. Fiksinski E; Martin D; Venditti F J Cardiovasc Electrophysiol; 1994 Feb; 5(2):144-5. PubMed ID: 8186884 [TBL] [Abstract][Full Text] [Related]
15. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes. Bhandari AK; Au PK; Rahimtoola SH Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424 [TBL] [Abstract][Full Text] [Related]
17. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans. Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998 [TBL] [Abstract][Full Text] [Related]
18. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. Dorian P; Newman D; Berman N; Hardy J; Mitchell J J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529 [TBL] [Abstract][Full Text] [Related]
19. Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia. Igawa M; Aonuma K; Okamoto Y; Hiroe M; Hiraoka M; Isobe M J Cardiovasc Pharmacol; 2002 Nov; 40(5):735-42. PubMed ID: 12409982 [TBL] [Abstract][Full Text] [Related]